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Abstract 
Objectives:  
To determine whether placement of an O-Cap reduces discomfort after temporary 
anchorage device (TAD) placement and to assess the expectations and discomfort 
experienced after TAD placement. 
Method: 
Ethical approval and research and development (R & D) permission was obtained 
from the different hospital sites. 30 patients (14 female, 16 male; mean age 14 years 
6 months) requiring bilateral TAD (3M Unitek) placement for maxillary anchorage 
reinforcement, completed short answer and 100mm visual analogue scale (VAS) 
questionnaires at different time-points prior to and 6 weeks following TAD placement. 
One of the TADs on each patient was randomly allocated to placement of an O-Cap 
(3M Unitek). 
Results:  
VAS scores were higher on the control side compared to the O-Cap side for all time-
points.  Wilcoxon signed-rank test showed statistically significant levels at 4 hour 
post-placement (p<0.05), 24hour (p<0.05) and 1 week (p<0.0005) for cheek 
discomfort and at 1 week (p<0.05) and 2 weeks (P<0.05) for gingival discomfort. 
Median VAS for cheek discomfort with O-Cap and control scored highest at 24 hours 
and 4 hours with 23 mm (0-100 mm) and 42.1 mm (0-94.9 mm) respectively. Median 
VAS for gingival discomfort with O-Cap and control scored highest at 1 hour post 
placement with 36.8 mm (0-100mm) and 48.4 mm (0-100 mm) respectively. Null 
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hypothesis rejected. 80% of subjects reported extractions to be more painful than 
TAD placement.  
Conclusions:  
Discomfort levels of the overall TAD experience were greatest during the first hour 
following placement. During the first 6 weeks the discomfort associated with an Imtec 
TAD was gradually reduced by placement of an O-Cap particularly as the local 
anaesthetic starts to wear off. 
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1.1 Introduction 
Anchorage in orthodontics can be defined as the resistance to unwanted tooth 
movement during treatment. This can be provided by intra-oral anchor sites like the 
teeth and palate, or alternatively extra oral devices such as headgear. Unfortunately 
these conventional methods have a major drawback: they all rely on patient 
compliance in order to be successful (Liou et al., 2004). Recent literature has 
suggested that the introduction of miniscrews or temporary anchorage devices 
(TADs), a term of American origin (Mizrahi and Mizrahi 2007), has created a potential 
to achieve the goals of ideal anchorage control.  
 
1.2 Terminology 
Successful skeletal anchorage is the main biological concept behind these devices 
and this involves 2 categories. Indirect anchorage use of such devices is defined as 
provision of immovable connections to the teeth, which serve as the actual 
anchorage units. On the other hand direct anchorage means utilisation of direct 
forces originating from the actual device itself, in this case the screws inserted into 
the bone. 
Osseointegrated dental implants, which include palatal implants and retromolar 
implants, fall into the former category. One commonly used mid palatal implant has a 
diameter of 3.75 mm and osseointegrated implants vary in length from 7 to 20 mm.  
Intra oral implants continued to develop into another category, the miniplates and 
miniscrews. Miniplates are attached to cortical bone by miniscrews and are 
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commonly inserted into the mandibular buccal bone or maxillary zygomatic buttress 
(Wahl, 2008). Osseointegration is not a desired feature in this particular category, as 
it would complicate removal, nor has it been found to be necessary for successful 
clinical use. 
Onplants are another completely different category from implants, they are placed 
sub-periosteally and are meant to integrate to the outer surface of cortical bone. 
These are manufactured as flat, titanium discs, sometimes with hydroxyapatite-
coated surfaces to encourage bone integration. Onplants have been reported to 
withstand orthodontic forces of up to 311g (Hong, 2005). 
 
1.3 Method of review: 
A Medline, PubMed and Cochrane Clinical Trials Register (CCTR) search was 
conducted using the following keyword search: 
• Orthodontic miniscrews OR mini implants OR microscrews 
• Success of miniscrews OR mini implants OR microscrews 
• Temporary anchorage devices 
The total number of 105 papers found, were manually sifted to exclude any, which 
involved in-vitro or animal studies. The final collection of 72 papers included in this 
search was divided into the following groups: 
• Clinical trials  
• Case reports 
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• Comparison reports between TADs and other anchorage devices 
• Relevant papers about history, surveys and types of miniscrews  
• One paper about ongoing national audit processes has also been included. 
 
1.4 History of implants 
The first reported attempt of intra oral anchorage with metal screws was carried out 
on dogs, by Gainsforth and Higley (Gainsforth and Higley, 1945).  After the 
introduction of osseointegrated implants in restorative dentistry and oral surgery in 
the 1960s, it became widely accepted that this new armamentarium could be a useful 
source of anchorage in orthodontic practice (Mizrahi and Mizrahi, 2007). It was at this 
time that Bränemark published a series of experimental studies demonstrating the 
successful stability of titanium implants to bony interface. 
One of the earliest successful results with miniscrews was in 1983 when a report was 
published about incisor elevation using a screw placed in the anterior nasal spine 
region (Creekmore and Eklund, 1983). It was not until the 1990s that further 
experiments with non-osseointegrated titanium microscrew implants were published 
by Kanomi and Melsen consecutively (Kanomi, 1997; Melsen et al., 1998). Roberts 
first published studies about successful closure of first molar extraction sites utilising 
mini-implants in the retromolar region as anchorage (Roberts et al., 1990). 
The mid-palatal implant was first described in 1992 by Triaca and colleagues (Triaca 
et al., 1992). Straumann Limited later developed the Orthosystem where a short 
cylindrical implant is placed into the palatal vault for a period of 12 weeks before it is 
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loaded. Experiments involving onplants, an indirect method of anchorage, were 
reported by Block and Hoffman in 1995 (Block and Hoffman, 1995). This evidence 
was however based on a dog and monkey study, both samples were of not more 
than 7 subjects. Following this successful period, it was Kanomi, in 1997, who 
described a mini implant exclusive for orthodontic use (Kanomi, 1997). Costa et al 
then described a 2mm diameter titanium miniscrew that could be used for direct or 
indirect anchorage in a preliminary report published the year after. This looked 
particularly at anchorage problems and relative solutions associated with deficient 
dentitions by evaluating the evidence on bone quality in dry skulls (Costa et al., 
1998). 
 
1.5 Clinical application  
Titanium has long been established as the material of choice for implants but new 
clinical applications for these anchorage devices are still in early stages of 
development. The burgeoning numbers of case reports in peer-reviewed journals are 
continuing to illustrate the versatility of TADs and their use in any clinical situation 
where anchorage is of concern.  
DeVincenzo published a series of papers in 2006, showing how the use of TADs 
successfully corrected potentially surgical, high-angle cases (DeVincenzo 2006). In 
the same year Prabhu and Cousley also reported on a couple of commercial mini-
implant systems available providing various anchorage solutions (Prabhu and 
Cousley,  2006). 
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The main indications for TADs to date have been: 
• Reinforcement of anchorage 
• Movement of buccal teeth in a mesial or distal direction 
• Movement of anterior teeth in a lingual or labial direction 
• Correction of crossbite or scissor bite (Young 2007) 
• Movement of buccal or anterior teeth in a vertical intrusive direction (Mizrahi and 
Mizrahi, 2007; Baumgartel et al., 2008; Cacciafesta, 2009)  
 
1.6 Classification of miniscrews 
Mini implants or mini screws have been classified in various ways:  
• Position: the site of anchorage is dictated by the type and severity of the 
malocclusion. The most common insertion site is the endosseous position but 
others may include subperiosteal or transosseous. 
• Implant surface may be rough or smooth. 
• Screw design: determines the extent of support it attracts from its surrounding 
bone. The smooth, cylindrical design is thought to increase such support 
(Wahl, 2008). Self-drilling or self-tapping (thread-forming) miniscrews 
eliminate the necessity of drilling pilot holes. Various miniscrew head designs 
are also available; namely the bracket head or button head design as well as 
the through hole design. The main purpose for these differing designs is to 
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meet various skeletal anchorage needs by enabling the miniscrew to accept 
wires, hooks and elastics or even act as a slightly unconventional bracket. 
TADs are also produced in various lengths between 5 mm and 12 mm, and 
with diameters of 1.2 to 2.0 mm. 
Examples of current systems include self-tapping screws such as the Tomas, Imtec 
and the Orthoimplant. The Aarhus Mini-implant, originating from Denmark provided 
the possibility of immediate loading of such screws (Sherwood et al., 2002). The 
Spider Screw, which has been popularised in Italy has a similar cylindrical design. 
Another popular self-drilling screw is the AbsoAnchor system developed in Korea by 
Dr Park and colleagues (Block and Hoffman, 1995).  
 
1.7 Clinical Success: 
Though the use of miniscrews has become widely popular and is one of the hot 
topics in current orthodontic discussions, there is still a lack of sound scientific 
evaluation in the form of clinical randomized controlled trials. The number of case 
reports on this subject is enormous with over 3300 at last count (Reynders et al., 
2009) and continues to expand, but unfortunately these tend to merely illustrate 
different techniques and versatility of applications.  
Buschang et al. recently published the results of an electronic survey on the 
worldwide use of miniscrews amongst members of the American Association of 
orthodontics. 42.6% of the respondents had placed over 10 screws and interestingly 
more than half were now placing their own screws rather than referring this 
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procedure to their surgical colleagues. It also seemed popular to use a combination 
of topical and local anaesthetic for placement of screws (Buschang et al., 2008; 
Cacciafesta, 2009). The majority of clinicians had not received any specific training 
prior to their first screw placement, and this was reflected in lower failure rates in the 
more experienced and satisfied operators (Buschang et al., 2008).  
 
1.8 Efficacy  
Osseointegrated dental implants such as the mid-palatal implants have been 
reported to have a success rate ranging from 85% to 100% from human studies. 
Success rate in such cases was defined by National Institute for Health and Care 
Excellence (Ni(H)CE) as stable anchorage for 1 year or until completion of orthdontic 
treatment (Moon et al., 2008). Animal studies in non-osseointegrated miniscrews 
have reported a success rate of 91% to 100%, however these types of studies do not 
portray a realistic clinical situation. A few human studies published in recent years 
have revealed a success rate of more than 75% when orthodontic forces of 100g-
400g are applied to such devices (Janssen, 2008; Reynders et al., 2009; Cheng 
2004; Kim et al., 2010; Kuroda et al., 2007; Asscherickx et al., 2010; Park et al., 
2006). Comparative trials between mini-implant anchorage and conventional 
anchorage such as headgear showed that the former provide faster and effective 
anchorage reinforcement in cases of absolute anchorage (Upadhyay et al., 2008; 
Thiruvenkatachari et al., 2008; Skeggs et al., 2009; Yao et al., 2008; Deguchi et al., 
2008; Benson et al., 2007). 1.2mm diameter and 8mm length miniscrews have been 
reported to be the most popular and successful. Crismani et al concluded that flap 
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versus flapless and immediate versus delayed miniscrew loading resulted in similar 
successful outcomes (Crismani et al., 2010). 
Failure of miniscrews has been reported to vary from 10% to 18% in recent years, 
and is the most common reported complication in the literature (Mizrahi and Mizrahi, 
2007; Baumgartel et al., 2008; Miyawaki et al., 2003; Tsaousidis and Bauss, 2008). 
Breakages of miniscrews are rare because bone is not able to offer sufficiently high 
resistance. It is usually advised to remove the miniscrew if resistance is encountered. 
The clinician should also ensure that the mini-implant is not directed into a root 
(Cacciafesta, 2009). 
 
1.8.1 Failures of miniscrews 
Contraindications for TADs are minimal and may include any systemic disease that 
results in poor bone quality. Locally it is contraindicated to place a miniscrew in a 
young child, especially in an area of a permanent successor or insufficient 
interradicular space.  
The main reported factors to contribute to miniscrew failures are: 
Ø Improper surgical technique/ loading protocol 
Ø Placement site 
Ø Host factors – smoking, management factors, parafunctional habits, bone 
quality, high mandibular angle that is thin cortical bone  
Ø Implant structural elements  
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Ø Soft tissue response 
Ø Excessive force application 
Chen et al reported in their systematic review, that choice of implant size should 
depend on the quality and quantity of bone available. Immediate implant loading 
showed high success rates with direct forces of up to 200g and resulted in shorter 
treatment time, but this evidence was regarded as secondary quality (Crismani et al., 
2010; Chen et al., 2009). Luzi et al also reported on the effectiveness of immediately 
loaded mini-implants, suggesting that the overall failure rate is not altered, especially 
when light forces are employed (Luzi et al., 2007). 
Patients who smoke or are currently on bisphosphanates predispose to higher failure 
rates and should only be treated on case to case basis. Bayat reported a significantly 
higher failure rate of orthodontic miniscrews in heavy smokers than light or non-
smokers (Bayat and Bauss, 2010). 
The main factors influencing the clinical success rate of mid-palatal miniscrews are 
the patient’s age, with patients younger than 15 years increasing the failure risk; 
operator’s skill (Garfinkle et al., 2008); placement of miniscrew in the palatal suture 
(Kim et al., 2010). 
Despite the implication of these factors in miniscrew failures, stability or loosening of 
the screw is difficult to predict, therefore each patient should be warned of the 
possibility of failure during the consent process. 
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1.8.2 Operative factors 
Several clinical guidelines on the placement have been proposed. Miniscrews are 
typically placed under topical or minimal local infiltration anaesthesia. They can be 
drilled or screwed into the bone cortex using a screw-driver or a contra-angled driver, 
either with or without prior pilot hole placement. Procedure time ranges from 5 to 15 
minutes depending on the operator and the patient (Gelgor et al., 2004; Chen et al., 
2006). Lee et al described the premolar and subapical areas in the anterior region as 
being the most reliable for orthodontic miniscrew placement. A depth of more than 
4mm of alveolar bone is easily available in intermolar regions and between the 
second premolar and the first molar in both arches (Tsaousidis & Bauss, 2008; Lee 
et al., 2009). Adequate bone depth and miniscrew orientation will affect the 
resistance to failure on the implant-bone interface. It was suggested that the long 
axis of the miniscrew should be closely approximated to the line of applied force 
giving greater stability in all dimensions (Pickard et al., 2010). Miniscrew placement 
in 2 stage surgery, at a high level, in non-keratinised mucosa has been reported to 
promote an unwelcome inflammatory hypertrophic tissue response, a significant 
predictor for failure especially in the mandible (Park et al., 2006; Viwattanatipa et al., 
2009). 
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1.9 Safety 
Despite all the possible insertion sites discussed, probably the most common would 
be in the keratinised gingivae of the interradicular space between upper second 
premolar and first molar. This choice of site would invariably raise the possibility of 
root damage during insertion of the device or during tooth movement. Clinical and 
histological observations of this have shown that the respective root areas react by 
initiating resorptive processes. However, reports have demonstrated that elimination 
of contact, will swiftly lead to cementum deposition and full root recovery within a few 
weeks (Kadioglu et al., 2008; Maino et al., 2007). 
Poggio et al suggested 1mm safety margin between a miniscrew and a root for both 
periodontal health and miniscrew stability. It could be also therefore recommended 
that miniscrews with a diameter of 1.5mm or less are adequate for insertion into an 
interradicular bone of at least 3.5mm (Poggio et al., 2006). 
Unfortunately the conclusions from these studies on safety are based on small 
patient samples and further work in this field is required. 
 
1.10 Pain 
The International Association of the Study of Pain (IASP, 1994) defines pain as an 
unpleasant sensory and emotional experience associated with actual or potential 
tissue damage or is described in terms of such damage. Patients have been found to 
avoid seeking orthodontic treatment due to fear of pain and for 95% of these patients 
pain has also been the main reason for discontinuing treatment (Oliver and 
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Knapman, 1985). Orthodontists, however tend to underestimate the pain thresholds 
experienced by their patients (Krukemeyer et al, 2009).   
There is great individual variation in levels of pain experienced and this can prove to 
be very subjective. The literature (Ngan et al, 1989; Brown and Moerenhout, 1991; 
Firestone et al, 1996; Bergius et al, 2000; Kluemper et al, 2002) suggests that pain is 
dependent upon various factors such as age, sex, emotional state and previous pain 
experience.  
Tucker et al. (1989) measured the cutaneous pain threshold in ages 5 to 105 years 
and showed that pain levels increase up to 25 years of age, than plateau off to then 
increase again gradually by age 75. In the orthodontic context, the published 
literature has on the contrary shown that younger patients experience less pain than 
older patients (Fernandes et al., 1988; Brown et al., 1991; Jones et al., 1992). 
Despite these claims Ngan et al., (1989) and Bergius (2002) have found no 
difference with age. 
The gender factor in relation to pain experience also presents divided thought in 
reported studies. Scheurer et al (1996) and Bergius et al (2002) reported that 
females tend to experience greater pain than males during orthodontic treatment but 
Ngan et al (1989) and Erdinc and Dincer (2004) showed no difference in the pain 
experienced during orthodontic treatment between genders. Soft tissue complaints 
and ulceration have been found more commonly in females than males (Kvam et al 
1989) but this could be attributed to the fact that there is a higher female predilection 
for recurrent aphthous ulceration.  
In humans higher centres of the central nervous system modulate pain levels, which 
are therefore highly affected by emotional and cognitive factors. An increase in 
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anxiety is often correlated with higher pain levels. Similarly positive motivation 
towards treatment and its results may lead to a reduction in anxiety and subsequent 
pain levels. This could be explained by filtration of painful stimuli and favourable 
alteration of pain thresholds (Bergius et al., 2000; Krishnan, 2007). Sergl et al. (1998) 
suggested that the level of acceptance of orthodontic treatment is related to the level 
of discomfort experienced after fitting of orthodontic appliances.  
There are different cultural variations in the level of pain experienced where some 
ethnic groups believe that pain expression should be sympathised whereas others 
behave oppositely. Northern Europeans are lass likely to report pain as other people 
of Italian or Jewish origin (Bergius et al., 2000).   
 
1.10.2 Causes of orthodontic pain 
Potentially painful procedures as described by the orthodontic literature include:  
• Placement of separators 
• Placement and activation of archwires 
• Functional appliances 
• Removable appliances 
• Headgear  
• Placement of temporary anchorage devices 
• Debonding 
In order to improve patient experience it is important to recognise which procedures 
cause pain during orthodontic treatment so the same patient can be warned of the 
risk of pain occurring during their treatment. 
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1.10.3 Pain associated with placement of Temporary anchorage devices 
Temporary anchorage devices (TADs) are usually placed chairside using minimal 
local anaesthetic to provide soft-tissue analgesia. The placement of TADs has been 
compared to other orthodontic procedures (Lee et al., 2008) and 78% of patients 
believed that they would experience greater pain than they actually experienced. 
Kuroda et al., 2007 also established that TADs, which are placed without any 
incisions or mucoperiosteal flaps, are significantly more comfortable. This could be 
explained by the potentially less soft tissue damage when TADs are placed 
transmucosally.  
 
1.10.4 Patient’s experience of TAD placement 
Patient compliance is very important for successful orthodontic treatment and is 
usually quite dependent on their pain experience. The literature is quite scarce on 
evidence for toleration of TADs by patients (Cornelis et al., 2008). Asscherickx et al., 
(2010) and Lee et al., (2008) have rated placement of TADs less painful to other 
orthodontic procedures or even tooth extractions, even though patients usually 
expect otherwise.  
 
1.11 Assessment of pain 
Pain is a very subjective experience and there is a lot of individual variation hence 
the need to assess it in an indirect manner. The visual analogue scale, the verbal 
rating scale and the numerical rating scale are examples of unidimensional scales 
that measure intensity of pain. These are incorporated in self-administered 
questionnaires often in turn used to assess acute pain. On the other hand the McGill 
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pain questionnaire is an example used to measure chronic pain. From published 
studies it can be determined that orthodontic pain is often assessed using the visual 
analogue scale, the numerical rating scale or a modified form of the McGill pain 
questionnaire. 
 
1.11.1 Visual analogue scale 
The visual analogue scale consists of a line, usually 100 mm long, which denotes the 
extremes of pain at its ends (see figure 1.11). The patient is asked to mark the level 
of his or her pain at a particular point along the line. The pain score is determined 
from the measured distance of the mark along the scale. This scale is a reliable and 
sensitive method of measuring pain and the effect of pain reducing methods. It also 
allows the patient to choose the exact intensity of the pain experienced without bias 
(Huskisson, 1974; Seymour et al., 1982 and 1985). Patients of age 5 and over are 
able to understand and fully complete a given visual analogue scale (Bergius et al., 
2002). 
 
      No pain               Worst pain  
         imaginable   
                     
l______________________________________________l    
 
Figure 1.11 The visual analogue scale 
 
1.11.2 Verbal rating scale 
Verbal rating scales are made up of a ranked list of words that describe pain rather 
than a measurable scale. The patient needs to choose the word that describes best 
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his or her level of pain. These scales are quite easy to use but tend to be less 
sensitive to differences between levels of pain than other scales (Searle et al., 2008).   
 
1.11.3 Numerical rating scale 
Numerical rating scales give an indication of pain level by the patient giving a score 
usually from one to ten with no pain at one end and worst pain at the other end.  
 
1.11.4 The McGill pain questionnaire 
The McGill pain questionnaire (Melzack, 1975) is more versatile but classically 
consists of three sections. A descriptive scale to record the current pain intensity, a 
diagram of a human where the pain location gets marked and a pain-rating index 
based on the selection of words from 20 different categories. This scale tends to be 
time consuming even though it has been found very useful in pain studies (Sokka, 
2003). 
 
1.11.5 Clinically significant difference in pain scores with visual analogue 
scales 
Clinical management of pain is performed using either pharmacological or non-
pharmacological methods. Most studies that have set out to determine the clinically 
significant pain score reduction in young people have been carried out in Accident 
and Emergency departments on children and adolescents in acute pain. The range of 
clinically significant reduction in pain scores on a 100 mm VAS has been reported to 
be from 10 mm (Powell et al., 2001) to 13 mm (Todd et al., 1996). There have not 
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been any further studies to determine clinically significant reduction in pain levels for 
orthodontic patients to the best of the author’s knowledge. 
 
1.12 Pain control during orthodontics 
There is a wide variation of pharmacological and non-pharmacological methods that 
have been used to reduce pain caused by orthodontic intervention: 
• Non-steroidal anti-inflammatories (NSAIDs)  
• Bite wafers 
• Transcutaneous electrical nerve stimulation (TENS)  
• Low level laser use.  
 
1.12.1 Pharmacological control 
The literature includes several studies that have investigated the effect of different 
analgesics successful in reducing orthodontic pain (Ngan et al., 1994; Steen Law et 
al., 2000; Arias et al., 2006; Bradley et al., 2007; De Carlos et al., 2007).  
Non-steroidal anti-inflammatories (NSAIDs) reduce orthodontic pain by inhibiting the 
inflammation caused by orthodontic force. The mian mode of action is by peripherally 
stopping the synthesis of prostaglandins at the site of injury through inhibition of the 
cyclo-oxygenase enzymes (COX-1 and COX-2). Phospholipase A2 cleaves 
arachidonic acid from the phospholipid cell membrane and the COX enzymes act on 
the arachidonic acid to produce prostaglandins. There is a major concern though that 
long-term use of NSAIDs might inhibit tooth movement.  
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Paracetamol acts centrally by inhibiting COX-3 enzymes in the brain and spinal cord. 
Bradley et al. (2007) compared the effects of ibuprofen with paracetamol and 
concluded that ibuprofen was more successful in the controlling orthodontic pain. In 
contrast a study by Bird et al. (2007) compared the reduction of pain from separators 
between the same mentioned anagesics and found no significant difference.  
 
1.12.2 Non-pharmacological control 
Low-level laser therapy theoretically is able to reduce pain by a non-thermal and a 
biostimulatory effect. There is either a direct effect on the nerve fibres that stabilises 
the depolarizing potential or by an inhibitory effect on inflammation. Dental 
applications of low-level laser therapy management of trigeminal neuralgia, dentine 
hypersensitivity and oral mucositis.  
 
Transcutaneous electrical nerve stimulation (TENS) inhibits the unmyelinated C-
fibres in the spinal cord and stimulates the A-β fibres (the gate control theory). Roth 
et al. (1986) found TENS effective in the reduction of pain when using separators.  
 
Chewing on a bite wafer to reduce pain has been a concept of split thought. Mangnall 
(2011) found that the pain experienced in the posterior during debond is significantly 
reduced by biting on an acrylic wafer. Other studies have found that bite wafers may 
increase the pain or made no difference at all (Hwang et al. 1994, Otasevic et al. 
2006, Bhogal et al. 2008).  
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The Tooth Masseuse is commercially designed to be used after bond-up and 
activation of fixed appliances to block the ischaemic response that results in pain. It 
produces vibratory effects to the teeth. This device may not always be tolerated well 
especially if used after the onset of pain (Marie et al., 2003). 
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2.1 Study aims 
The aims of the study are: 
• To determine whether the placement of an O-Cap (described to the patients as 
the different version of TAD) reduces the discomfort experienced after TAD 
placement 
• To determine the expectations of pain during placement of TADs  
• To determine the discomfort during placement of 3M Unitek TAD 
 
 
2.2 Null Hypothesis 
 
Placement of an O-Cap does not affect discomfort experienced in the first 6 weeks of 
treatment. 
 
2.3. Study design 
 
The study was designed as a pilot, multicentre split mouth randomised controlled trial 
of patients who need fixed orthodontic appliances supplemented with bilateral TAD 
placement for extra anchorage. The recruiting orthodontic departments included Mid-
Staffordshire NHS Foundation Trust, University Hospital of North Staffordshire, 
Birmingham Dental Hospital and Countess of Chester Hospital NHS Trust.  
All subjects who met the inclusion criteria were invited to take part and subsequently 
provided with an information leaflet together with the standard BOS leaflet on TADs. 
Once informed consent was obtained from the patient, the left and right halves of the 
mouth were randomly assigned to having a TAD or a TAD with an O-Cap placed. 
The subjects were asked to complete a set of questionnaires to determine their pain 
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experience prior to and following TAD placement at different time-points, 1 hour, 4 
hours, 1 week, 2 weeks and 6 weeks later at recall outpatient appointment. Patients 
participating in the study were also included in the national BOS Audit on miniscrews.  
The local collaborators in the trial were not aware of which side was assigned to 
receive the O-Cap until the time of TAD placement. The principal investigator (AP) 
who analysed the questionnaires was blind to the side allocations throughout the 
whole process. 
 
2.4 Ethical Approval and Research and Development approval  
Ethical approval was gained from the East Midlands and Derby Research Ethics 
Committee. Reference number: 11/EM/0394.  Local NHS Research and 
Development approval was gained for the four research sites and site-specific 
approval was also obtained from the respective local Research and Ethics 
Committees. 
 
2.5 Randomisation process  
30 sealed brown envelopes were used to conceal the side of the mouth to receive 
the O-Cap at the time of TAD placement. They carried equal numbers of left and right 
side assignment papers and were shuffled by an independent individual. The 
envelopes were kept in a locked office at one of the research sites and subsequently 
opened by an independent staff member at the time of TAD placement.  
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2.6 Sample size 
This is the first study to evaluate the effect of O-Cap placement on discomfort 
associated with TADs. Therefore, no formal sample size calculation is presented for 
this pilot study. We planned to recruit 25 patients and permission was gained for 
further recruitment in case of dropouts or TAD failures. 
 
2.7 Subjects 
30 subjects were recruited from April 2012 to March 2013 from the Orthodontic 
Departments at Mid-Staffordshire NHS Foundation Trust, University Hospital of North 
Staffordshire, and Birmingham Dental Hospital. All potential participants had been 
referred for orthodontic treatment and were approached at their first consultation 
outpatient appointment. They were invited to participate following full explanation 
about the purpose of the trial and provision of a letter of invitation along with an 
information sheet. For those under 16 years of age, their parent or guardian also 
received an information sheet.  
 
2.7.1 Inclusion criteria 
• Informed consent gained 
• Male/females under 18 years of age 
• Fully erupted upper second premolar and upper first permanent molar and 
sufficient space to allow TAD placement  
• Treatment plan of extraction of both upper first premolars  
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• Requirement for anchorage reinforcement which could be achieved with 
placement of two maxillary TADs between the upper second premolar and the 
upper first permanent molar to reinforce anchorage 
 
2.7.2 Exclusion criteria 
• Patients who had completed a previous course of orthodontic treatment as 
prior experience of treatment and discomfort could bias the results 
• Patients unable to comprehend or complete the questionnaire 
• Patients with cleft lip or palate or any other dentofacial deformity 
• Patients with previous surgery to the insertion site or planned orthognathic 
surgery 
 
2.8 Method 
Informed consent was obtained for each participant. All patients underwent thorough 
oral prophylaxis and pre-orthodontic restorative procedures prior to starting 
treatment. TADs were placed prior to any planned extractions and appliance 
placement to minimise confounding pain variables resulting from these procedures. 
At the time of TAD placement a sealed envelope was assigned for each patient 
according to the order in which he or she were recruited. Placement of TADs was 
carried out by 4 clinicians involved in the trial – JS, JS, LM, AP. All participants 
completed a questionnaire to determine their experience of TAD placement at 
different time-points. The first section of the questionnaire (A) investigated the 
expectations of discomfort during TAD placement, immediately prior to the 
procedure. There was a similar section (B) immediately post placement to find out 
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the exact nature of the patient’s experience of the actual procedure. Further sections 
followed at time points 1 hour (C), 4 hours (D) and 24 hours (E) after placement in 
order to investigate any changes in discomfort taking place as the analgesia wore off. 
The patient was then asked to complete the final sections of the questionnaires 1 
week (F), 2 weeks (G) at home and finally 6-8 weeks (H) later at the recall outpatient 
appointment. 
The questionnaire (please refer to Appendix 1) consisted of simple questions or 
completion of a visual analogue scale to determine discomfort. One of the local 
collaborators was always present whilst the questionnaires were answered to 
supervise and provide further information if required. 
 
2.8.1 Placement method 
The following placement method was agreed upon by all clinicians involved in this 
study in order to standardise the procedure. Prior to insertion, the interdental space 
between the maxillary second premolar and maxillary first molar was assessed for 
bone quality and quantity utilising the orthopantamogram taken previously as part of 
the initial orthodontic records. The TAD required a clear margin of at least 2.5mm 
between the roots of the teeth. The patient was asked to complete questionnaire A. 
Topical anesthetic gel (20% Benzocaine) was applied for 3 to 5 minutes on the 
attached gingivae where the TAD was designated followed by buccal infiltration of 
0.3ml of Lidocaine (2% Lignocaine 1:80,000 adrenaline) local anaesthetic in the 
adjacent free gingivae. This application was repeated for both the left and the right 
side. The planned site of insertion was clearly marked in between the distal and the 
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mesial root eminences of the maxillary second premolar and maxillary first 
permanent molar respectively using a Williams periodontal probe (Figure 1). The 
patient was asked to rinse for a minute with 15ml of 0.12% Chlorhexidine Gluconate 
mouthwash. This was followed with placement of self-threading TADS bilaterally at 
450 to 900 just below the junction between the attached and free gingivae. Each TAD 
was inserted until half the cuff was buried. An O-Cap was then placed only on the 
TAD, indicated by the random allocation. The patient was asked to complete 
Questionnaire B immediately after placement of TADs and O-Cap and the remaining 
questionnaires C to G were given to the patient to take home for completion at the 
respective time-points as specified on them. Permission was granted to the principal 
investigator by each participant and or parents to send text reminders at the 
appropriate time to ensure completion of questionnaires. The final questionnaire H 
was completed at the recall outpatient appointment. At this point the TAD was 
engaged with the bracket of the maxillary second premolar using a 0.010” stainless 
steel ligature wire, which was passed through the hole of the head of the implant. An 
extraction letter for removal of both upper first premolars was also given and bonding 
of upper and lower fixed appliances was planned for the subsequent visit. 
 
2.8.2 TAD and O-Cap 
Titanium self-threading TADs of 1.8mm diameter and 6mm tapered length were used 
in this trial. The design is composed of a 2.4mm head with holes attached to a 
1.5mm squared cuff (Figure 2). The TAD used in the trial is a product manufactured 
by 3M Unitek and was particularly chosen because it is one of the few products of its 
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type to come available with an adjunctive O-Cap designed to protect soft tissues and 
as a means of attachment for auxilliaries. The O-Cap, which is supported by a rubber 
O-ring, is designed to fit tightly over the head of the TAD and also has a retentive 
groove at the neck. 
 
 
Figure 2.8.1 TAD insertion site  
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Figure 2.8.2. Imtec TAD and O-Cap (courtesy of 3M Unitek) 
 
 
Figure 2.8.4 Self-threading O- driver  
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2.8.3 Questionnaires  
Each patient was asked to complete an anonymised questionnaire (see appendix 1) 
with 8 short sections labelled A to H according to different time-points and rate the 
severity of their discomfort using a visual analogue scale (VAS). The 100 mm line 
was labelled at the extremes with "no pain" and a happy face and "worst pain 
imaginable" and a sad face. Similar faces were also placed at 20 mm intervals along 
the same line. The subjects placed a vertical line on the scale to mark the point 
corresponding to their level of pain. Comment boxes were also added to give the 
participants an opportunity to express any added concerns or remarks. 
The first section (A) completed immediately prior to TAD placement enquired about 
the perceived expectations and discomfort that the patient would experience during 
the intervention. A comment box enquired about any specific concerns that the 
patient might have at that point. The second questionnaire (B) recorded the amount 
of pain experienced during the intervention. The patient was asked to compare the 
discomfort experienced immediately after placement between the cheeks of each 
side. A comment was also included here to allow the patient to comment on their 
worst perceived aspect of the intervention. Similarly the following questionnaire (C), 
which was completed an hour after the TADs placement, included visual analogue 
scales for the patient to score the amount of pain experienced for the soft tissues of 
the cheeks and gingivae on each side together with a comment box on any pain relief 
that was required to control the pain. Questionnaires D to G followed the same 
pattern of questions applied to different time-points 4 hours as the local anaesthetic 
started to wear off, 2 hours, 1 week, 2 weeks and 6 weeks later. The final 
questionnaire (H) completed at recall outpatient appointment, also asked the patient 
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to identify which intervention was the most uncomfortable from having TADs placed 
or teeth extracted. This was completed at the bond-up appointment once the 
extractions had been carried out by the general dental practitioner.     
The visual analogue scale scores were measured using digital callipers by one 
operator (AP). The operator was blinded to the group.  Intra-examiner reliability for 
the measurement of the VAS was tested by re-measuring 15 questionnaires one 
month later. 
 
2.8.4. Outcome measurements 
The completed questionnaires represented the severity of discomfort experienced by 
the patient on visual analogue scales at different time-points.  
Primary endpoint: 
The primary endpoint is the difference in soft tissue discomfort levels as measured 
on the VAS between sides with O-Cap and sides without O-Cap. 
Secondary endpoints: 
- Anticipated level of discomfort with TAD placement  
- Perceived level of discomfort with TAD placement 
- Perceived level of discomfort associated with TADs at different time points  
- Perceived level of discomfort associated with soft tissues around TADs at 
different time points 
- Any adverse events 
- Retention rates 
- Proportion of patients who completed study 
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2.8.5 Statistical analysis 
All statistical analysis were performed with STATA 11.2 (Statacorp., College Station, 
TX, U.S.A). 
The resultant data was not normally distributed and so the effect of placing an O-Cap 
on the TAD was assessed using Wilcoxon signed rank test, a non-parametric 
statistical test.  
Spearman's Rank correlations were determined between the overall pain 
experienced during the placement of TADs, the level of anxiety prior to placement 
and the overall pain expected during the placement.  
 
Descriptive statistics were used to determine the most painful time-point for gums 
and cheeks following the placement of TADs. 
 
The intra-examiner reliability for the measurement of the VAS was assessed using 
intraclass correlation coefficient following re-measurement of 15 VAS, 3 months 
apart.  
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3.1 Baseline results 
3.1.1. Descriptive data 
A favourable ethical opinion was granted in January 2012 by Derby Research Ethics 
Committee (Reference number 11/EM/0394). The recruitment of participants 
commenced on April 2012 and was completed in May 2013. The sample consisted of 
30 subjects all of whom agreed to participate in the trial when approached during 
their outpatient new patient appointment. 18 subjects were recruited from Mid-
Staffordshire District General Hospital, 10 from University Hospital of North Staffordshire 
and 2 from Birmingham Dental Hospital. Overall there were more males than females 
(16 males, 14 females). The age of the patients ranged from 10 years 11 months to 
18 years with a mean age of 14.64 years, see table 3.1.1. 
All the patients accepted for orthodontic treatment in all hospital sites involved 
underwent a course of oral health education to standardise oral hygiene and avoid 
any complications from gingival inflammation. There were 60 TADs placed under 
local anaesthetic for this trial with 30 O-Caps randomly placed on one TAD in the 
allocated side. Equal numbers of O-Caps were allocated to left as to the right hand 
sides of subjects in the sample. Hundred percent response rate was achieved for the 
questionnaire provided but section H was not completed for three patients due to 
failure of four anchorage devices. Out of these subjects, one lost the TADs bilaterally 
and two subjects lost a TAD unilaterally. There was no specific cause determined for 
the failure of the TADs and an alternative anchorage solution was sought for the case 
with bilateral failure whilst the TAD was replaced for the cases with unilateral failure. 
In total four TADs failed during the trial period of 6 weeks giving an overall failure rate 
of 6.7%.  
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  Control 
O-Cap 
Total 
Left Right 
TADs 
Number 30 15 15 60 
Males (%) 16 (26.7) 11 (18.3) 5 (8.3) 32 (53.3) 
Females (%) 14 (23.3) 4 (6.7) 10 (16.7) 28 (46.7) 
Age 
(years) 
Mean (SD) 14.6 (1.6) 
Median 14.5 
Minimum 10.9 
Maximum 18.1 
Table 3.1.1 Descriptive data 
 
3.1.2. Expectations of overall experience of placement of TADs  
The subjects marked their level of anxiety prior to having the TADs placed under 
local anaesthetic, see table 3.1.2. Overall the VAS pain scores varied considerably 
and ranged from 0 to 79.2 with a median score of 20.2. 
Fifty percent of the completed comment boxes expressed concerns about having the 
local anaesthetic as part of the TAD placement. 33.7% of the subjects were 
concerned over the pain that the placement of TADs or the local anaesthetic injection 
could involve whilst 17% were worried about the feeling of having the “TADs inside 
the gums”. The remainder of the comments expressed no concerns or left the box 
vacant. 
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3.1.3. Expectations of pain during the placement of TADs  
VAS scored in section A of the questionnaire illustrated the level of anxiety about 
pain of the subjects during the placement of the TADs under local anaesthetic. The 
range extended from 10.3 to 80.5 with a median of 39.9.  
 
Figure 3.1.1 A box and whisker plots for the overall level of anxiety prior to and the 
actual expectations of discomfort experienced by the patient during the placement of 
TADs. 
 
The box represents the 25th to 75th percentiles with the 50th percentile, also 
representing the median, indicated by the black line. The whiskers indicate the range, 
the minimum and maximum of the ranked values of the VAS scores.  
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TIME-POINT VAS SCORES 
Level of anxiety prior to 
placement of TADs 
Mean (SD) 27.8(18.8) 
Median 20.2 
Range 0 – 79.2 
Expectations of pain during 
placement of TADs 
Mean (SD) 45.7(18.3) 
Median 39.9 
Range 10.3 – 80.5 
Table 3.1.2 Baseline results – VAS scores prior to placement of TADs 
 
3.2 Results  
3.2.1 Actual pain experienced during the placement of TADs 
The subjects rated the level of pain they experienced during the placement of TADs 
after local anaesthetic administration. The range of VAS scores varied from 0 to 68.5 
with a median of 13.7.  
There highest VAS scores were recorded 1 hour following the placement of TADs, 
following which the subjects reduced their scorings throughout the subsequent 6 
weeks, as assessed by the different time-points in the different sections of the 
questionnaire, see table 3.2.1. 
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Figure 3.2.1 A box and whisker plot for the actual pain experienced during the 
placement of TADs and the following 6 weeks 
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Pain with placement of 
TADs at different time-points VAS SCORES 
During placement of TADs 
Mean (SD) 17.4(19.4) 
Median 13.7 
Range 0 – 68.5 
1 hour 
Mean (SD) 47.7 (24) 
Median 40.9 
Range 0 – 94.2 
4 hours 
Mean (SD) 41.1 (23.3) 
Median 38.8 
Range 0 - 100 
24 hours 
Mean (SD) 31.2 (23.6) 
Median 28.6 
Range 0 – 79.8 
1 week 
Mean (SD) 19.5 (22.6) 
Median 13 
Range 0 – 79.9 
2 weeks 
Mean (SD) 14.4 (19.7) 
Median 8 
Range 0 – 78.5 
6 weeks 
Mean (SD) 9.1 (11.7) 
Median 1 
Range 0 – 39.7 
Table 3.2.1 Results – VAS scores for actual pain during the placement of TADs and 
the subsequent 6 weeks after the placement of TADs  
 
Overall, the VAS scores rated prior to the placement of the TADs were higher than 
the VAS scores rating the actual pain experienced during the procedure, see figure 
3.2.2. However, the VAS scores for the pain expectations were comparable to the 
high scores rated for the pain experienced 1 hour following the placement of the 
TADs. 
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Figure 3.2.2 A box and whisker plot for the comparison between the patients’ 
expectations and actual pain experienced during the placement of TADs 
 
When the subjects were asked: 
“What was the worst part of having the TAD placed?” 
 in Section B of the questionnaire, 33% felt that the local anaesthetic injection and the 
numbness were most uncomfortable. 23% of the subjects did not like the sensation 
of the TADs being inserted and 23 % did not feel that there was an uncomfortable 
instant at all during the procedure. The remainder of the subjects commented on 
slight pressure felt on insertion of the TADs and the stretch of the cheeks.  
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3.2.2. Discomfort experienced in the cheeks after placement of TADs without 
the O-Cap 
Each subject scored the VAS in each section from B to H in the questionnaire to rate 
their level of discomfort of the cheeks bilaterally following placement of the TADs 
under local anaesthetic. The sections B to H covered the time period of immediately 
after, 1 hour, 4 hours, 24 hours, 1 week, 2 weeks and 6 weeks after the placement of 
the TADs, see table 3.2.2. The subjects could not be blinded as to which side 
received the TAD with the O-Cap but were told that the TADs inserted were different 
to each other in order to reduce bias. 
The levels of discomfort of the cheeks were highest at 4 hours following placement of 
the TADs, with VAS scores ranging from 0 to 83.7 having a median of 42.1. The 
scores reduced consistently following the first day reaching the lowest level of 
discomfort at 6 weeks with VAS scores ranging from 0 to 40.4 with a median of 9.1. 
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Figure 3.2.3 A box and whisker plot illustrating the levels of discomfort experienced in 
the cheeks after placement of TADS without O-Caps 
 
3.2.3 Discomfort experienced in the cheeks after placement of TADs with the 
O-Cap 
The VAS scores for the side with the TAD that received an O-Cap were higher than 
the VAS scores for the side without the O-Cap initially at the time of placement but 
reduced consistently following this time-point to a reach the lowest VAS scores 
recorded for cheek discomfort at 6 weeks. The scores at this time-point ranged from 
0 to 53.6, with a median of 0.  
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Figure 3.2.4. A box and whisker plot illustrating the levels of discomfort experienced 
in the cheeks after placement of TADS with O-Caps 
 
3.2.4 Discomfort experienced in the gingivae after placement of TADs without 
the O-Cap 
Similarly to cheek discomfort, the subjects scored their level of pain experienced for 
the gingivae at different time-points on the questionnaire. These time-points included 
1 hour, 4 hours, 24 hours, 1 week, 2 weeks and 6 weeks after the placement of the 
TADs, see table 3.2.2.  
The levels of discomfort for the gingivae of sides with TADs without O-Cap were 
highest at 1 hour following placement and then reduced throughout the period of 6 
weeks. The lowest scores were achieved at 6 weeks following placement once again 
and ranged from 0 to 59.5, with a median of 1.8. 
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Figure 3.2.5. A box and whisker plot illustrating the levels of discomfort experienced 
in the gingivae after placement of TADS without O-Caps 
 
3.2.5 Discomfort experienced in the gingivae after placement of TADs with the 
O-Cap 
The VAS scores for the levels of gingival discomfort associated with TADs, which 
received an O-Cap, followed a similar pattern to the ones for the TADs without the O-
Caps but were lower at every time-point.  
The levels of discomfort for the gingivae of sides with TADs with the O-Cap were 
highest at 1 hour following placement and then reduced throughout the period of 6 
weeks. The range of VAS scores at 1 hour following placement was from 0 to 100 
and the median was 36.6. The lowest scores were achieved at 6 weeks following 
placement once again and ranged from 0 to 50.6, with a median of 0. 
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Figure 3.2.6. A box and whisker plot illustrating the levels of discomfort experienced 
in the gingivae after placement of TADS with O-Caps 
 
3.2.6  Discomfort experienced with placement of TADs with and without O-Cap 
The VAS scores rated showed a large variation. The subjects rated their pain 
experience higher in the control group (without the O-Caps) over all the time-points 
from immediately after to 6 weeks after the placement of TADs see table 3.2.2. 
Overall, the VAS scores reduced over the 6 weeks following placement of the TADs 
for both discomfort in the cheeks and the gingivae, see figures 3.2.7.and 3.2.8. 
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Figure 3.2.7. A box and whisker plot for the discomfort experienced in the cheeks 
after placement of the TADs with and without O-Caps over 6 weeks 
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Figure 3.2.8. A box and whisker plot for the discomfort experienced in the gingivae 
after placement of the TADs with and without O-Caps over 6 weeks 
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Time-point after 
placement of TADs 
VAS scores for discomfort experienced  
Cheek Gingivae  
Control  O-Cap Control  O-Cap 
Immediately 
Mean (SD) 22  (18.6) 24.4 (21.4)   
Median 19.8 19.8   
Range 0 – 68.4 0 – 79.5   
1 hour 
Mean (SD) 38.4 (26.4) 28.2 (25) 47.6 (26.4) 37.6 (25.4) 
Median 37 19.9 48.4 36.8 
Range 0 – 100 0 – 100 0 – 100 0 - 100 
4 hours 
Mean (SD) 43.4 (23.7) 32.4 (25.1) 36.6 (27.3) 35.6 (27.9) 
Median 42.1 21.4 32.8 29.1 
Range 0 – 83.7 0 - 100 0 – 82.6 0 - 100 
24 hours 
Mean (SD) 45.2 (30.4) 27.9 (25) 26.5 (26.5) 20.8 (20.7) 
Median 41.8 23 29.9 18.8 
Range 0 – 94.9 0 - 100 0 – 96.2 0 – 79.4 
1 week Mean (SD) 31.4 (28.9) 12 (17) 21.3 (23.6) 12.2 (15.8) Median 29.2 6 18.8 3.3 
Range 0 – 100 0 – 79.2 0 – 79.2 0 – 58.6 
2 weeks Mean (SD) 14.7 (15.1) 9.5 (12.6) 13.7 (16.5) 8.9 (10.9) Median 12.7 2.6 6.1 3.1 
Range 0 – 51.2 0 – 43 0 – 52.1 0 – 38.3 
6 weeks Mean (SD) 14.1 (15.3) 7.8 (12.9) 13.2 (17.9) 8.4 (12.7) Median 9.1 0 1.8 0 
Range 0 – 40.4 0 – 53.6 0 – 59.5 0 – 50.6 
  
 
Figure 3.2.2 Results- VAS score data for the level of discomfort of the cheeks and 
gingival experienced following placement of TADs with and without O-Cap 
 
When asked which side was more uncomfortable immediately after and over the 6 
weeks following placement of the TADs, more subjects rated the TAD with the O-Cap 
more uncomfortable during time-points 1 hour and 4 hours after placement. However, 
over the subsequent 24 hour to 6-week time-points, the TAD without the O-Cap was 
more uncomfortable. The subjects experiencing no difference in discomfort between 
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the left and the right sides increased as time passed following the placement of the 
TADs.  
 
Time-point after 
placement of TADs 
More uncomfortable side (% ratings) 
Control O-Cap Same Not rated 
Immediately after 30 37 33 - 
1 hour 30 47 23 - 
4 hours 37 33 27 3 
24 hours 47 26 27 - 
1 week 47 10 43 - 
2 weeks 27 13 57 3 
6 weeks 33 7 50 10 
Table 3.2.3. The percentage rating of the more uncomfortable side immediately after 
and over the subsequent 6 weeks following the placement of the TADs. 
 
 
3.2.7 Pain relief  
Sections C to H in the questionnaires (time-points 1 hour, 4 hours, 1 week, 2 weeks 
and 6 weeks after placement of TADs) asked the subjects whether any pain relief 
has been taken and which type was taken.  
47% of the subjects felt the need to take pain relief, which varied from paracetamol, 
ibuprofen, Beechams©, co-codamol and Bonjela©. The number of subjects taking 
pain relief reduced as more time passed following the placement of TADs until none 
of them were making any use of pain relief at 6 weeks following placement. 
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Figure 3.2.9. Bar graph illustrating the frequency of pain relief during the 6 weeks 
following the placement of TADs. 
 
3.2.8 Extractions versus placement of TADs 
Once the questionnaire was fully completed, at the recall outpatient appointment 6 
weeks following the placement of TADs, the subjects were given a subsequent 
appointment for bonding up of the fixed appliances, by which time both upper first 
premolars been extracted. At this appointment the subjects were each asked which 
of the two procedures, having the teeth extracted or the TADs placed, did they find 
most uncomfortable. 
80% reported that extraction of teeth was more uncomfortable, whilst 3% were 
unsure leaving the remainder percentage to subjects who felt that having TADs 
placed was more uncomfortable. 3 out of the latter 5 subjects commented that 
placement of TADs turned out to be worse than extractions of teeth because they 
had never experienced administration of local anaesthetic prior to having the TADs 
placed.  
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3.3 Analysis of the results 
3.3.1 Wilcoxon Signed Rank analysis of cheek discomfort levels of TADs 
with and without O-Caps 
Wilcoxon signed rank analysis was used to examine the effect of the O-Cap on the 
discomfort levels between the sides having the TADs with and without the O-Caps.  
The results showed the pain scores for the control group to be higher than those for 
the O-Cap group for all time-points. Wilcoxon signed-rank test showed statistically 
significant differences at time-points 4 hour post-placement (p<0.05), 24hour 
(p<0.05) and 1 week (p<0.0005) for cheek discomfort. 
Wilcoxon 
sign rank 
analysis 
Cheek discomfort: control versus O-Cap scores 
Immediately 
after 
1 
hour 
4 
hours 
24 
hours 
1 
week 
2 
weeks 
6 
weeks 
z - 0.743 -1.674 -2.30 - 2.107 - 3.508 -1.775 - 1.390 
Significance 
P value 
0.4577 0.094 0.0215 0.0351 0.0005 0.0759 0.1645 
Table 3.2.4 The Wilcoxon Signed Ranks Test to compare the cheek pain scores for 
TADs with and without O-Caps at different time-points after placement.   
 
3.3.2 Wilcoxon Signed Rank analysis of gingival discomfort levels of TADs 
with and without O-Caps 
The results for gingival discomfort showed that the pain scores for the control group 
were also higher than those for the O-Cap group for all time-points. Wilcoxon signed-
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rank test showed statistically significant levels at time-points 1 week (p<0.05) and 2 
weeks (P<0.05) for gingival discomfort. 
Wilcoxon sign 
rank analysis 
Gingival discomfort: control versus O-Cap scores 
1 hour 4 hours 24 hours 1 week 2 weeks 6 weeks 
z - 1.742 -1.026 - 1.315 - 2.473 -2.403 - 0.627 
Significance P 
value 
0.0815 0.3051 0.1883 0.0134 0.0162 0.5306 
Table 3.2.5 The Wilcoxon Signed Ranks Test to compare the gingival pain scores for 
TADs with and without O-Caps at different time-points after placement.   
 
3.3.3 Spearman's Rank Correlations 
The Spearman Rank correlation test was used to analyse the correlations between 
the rated VAS scores for the expected levels of discomfort prior to placement of 
TADs and those for cheek discomfort for TADs without O-Caps (control group). 
There were weak positive correlations, however none of them were statistically 
significant.  
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Cheek discomfort for control group 
1 hour 
4 
hours 
24 
hours 
1 week 
2 
weeks 
6 
weeks 
Expected 
pain 
scores 
Correlation 
Coefficient r 
0.2178 0.3286 0.0169 0.2054 0.1389 0.2424 
Significance 
P value 
0.2476 0.0762 0.9292 0.2763 0.4643 0.2051 
 
Gingival discomfort for control group 
1 hour 
4 
hours 
24 
hours 
1 week 
2 
weeks 
6 
weeks 
Expected 
pain 
scores 
Correlation 
Coefficient r 
0.2231 0.1738 0.1855 0.1221 0.1652 0.1406 
Significance 
P value 
0.2359 0.3585 0.3265 0.5205 0.3830 0.4669 
Table 3.2.7. Spearman’s rank correlations between expected pain VAS scores and 
cheek VAS scores for TADs without O-Caps. 
 
3.4  Intra-examiner reliability  
Intraclass correlation coefficient test was used for the measurement of the visual 
analogue scales was 0.99 indicating good intra-examiner reliability for the 
measurement of the visual analogue scale (see table 3.4.1). 
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Intraclass correlation 
95% confidence interval of the difference 
Number of observations 
0.9994 15 
Table 3.4.1 The intraclass correlation coefficient analysis for the intra-examiner 
reliability of the measurement of the visual analogue scale pain scores 
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4.1 Baseline results 
Anchorage has been defined as resistance to unwanted tooth movement. Over the 
past 60 years several methods have been developed to prevent anchorage loss with 
minimal patient compliance possible. Some of the variables for anchorage control are 
linked to diagnosis, treatment planning and treatment mechanics and are more 
dependent on the orthodontist. Others such as elastic wear and use of headgear are 
very dependent on patient compliance. The increased popularity and use of 
temporary anchorage devices has developed to reduce the risks of poor patient 
compliance in the hope of providing more predictable outcomes. They also offer 
increased versatility in supporting tooth movements, such intrusion of teeth, hitherto 
very difficult to achieve with conventional appliance mechanics.  
As new systems are continuously being introduced into the orthodontic market, there 
is a strong focus on improving the patient experience. This has been found to be 
strongly dependent on their experience of pain (Oliver and Knapman, 1985; 
Krukemeyer et al, 2009). However there is limited evidence on this aspect of skeletal 
anchorage. This trial investigated the effect an O-Cap has on the discomfort 
experienced by the patient following the placement of the temporary anchorage 
device. It also provided baseline data on patient expectations and pain experience in 
the early stages of Tad use.  
 
STUDY DESIGN 
The purpose of an O-Cap has been marketed by 3M Unitek as means of attachment 
of auxiliaries, preventing and soft tissue overgrowth and protecting adjacent soft 
tissue from trauma or irritation. Whilst practical experience suggests that the latter 
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benefit is helpful in clinical practice, there is no evidence to prove this. Hence the 
sample for this pilot trial could not based on a power of calculation from previous data 
and was carried out as a pilot study. A split mouth design was chosen to eliminate 
inter-individual variability from the treatment effect. Despite the commonly claimed 
disadvantage of carry-across effects, it was felt a crucial benefit to avoid problems 
caused by the subjectivity of pain. Pain has also been found to be dependent on 
other factors such as age, cultural differences and previous pain experience (Ngan et 
al., 1989; Bergius et al., 2000; Kluemper et al., 2002). The mean age of this sample 
was 14 years 6 months, reflecting the greater majority of the orthodontic patient 
population. Adults over age 18 years were excluded from the trial to minimise 
orthognathic cases and effects of age on results especially since pain threshold has 
been found to increase with older age (Woodrow et al., 1972). There was a slightly 
greater predilection for males in this sample. Most studies report no statistically 
significant differences in pain ratings between subjects of different gender (Ngan et 
al., 1989; Erdinç and Dinçer, 2004), but others have claimed that females may report 
more pain than males (Scheurer et al., 1996; Bergius et al., 2002). Ideally the gender 
number would have been completely balanced in the sample. 
The TADs placed were not loaded immediately, nor were fixed appliances placed. 
This was in order to avoid confounding factors from tooth pain and soft tissue 
discomfort which are typical during the early stages of treatment caused by 
inflammation due to tooth movement and from abrasion of fixed appliances against 
the soft tissues.  
Despite the increased popularity of temporary anchorage devices, the choice of an 
anchorage method may be down to clinician preference. Unless dictated by patient 
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circumstances, skeletal anchorage is used preferentially to other intraoral or extraoral 
anchorage methods at two of the hospital sites involved in this trial (Mid-Staffordshire 
Foundation Trust and University Hospital of North Staffordshire). At the third site 
(Birmingham Dental Hospital), the use of temporary anchorage devices is less 
common, hence the resultant reduced number of patients recruited compared to the 
Staffordshire sites. The fourth site Countess of Chester at this time were having 
issues with TAD failure and so although included in the original site planning had 
changed their preference for a different type of TAD and so no patients were 
recruited from this unit. 
 
TAD FAILURE 
The overall failure rate for the TADs in this trial was 6.7%. However favourable this 
may be, it is not necessarily comparable to the most recently published failure rate of 
13.5% from a meta-analysis (Papageorgiou et al., 2012). Success data is based on 
either having achieved the desired anchorage at the time of failure or removal. As 
this investigation dealt with the first six weeks of treatment only prior to engagement 
for anchorage these figures cannot be extrapolated as the true failure rate. It is 
however consistent with published data which show that unloaded TADs, if they fail 
at all, are likely to show reduced stability within the first three weeks of placement 
(Ure et al., 2011).  
 
EXPECTATIONS OF TAD PLACEMENT 
The general feeling about having the TADs placed and the level of pain expected by 
each subject was recorded to give a baseline comparison for the pain scores that 
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followed and to assess the relationship between expectations of pain and actual pain 
experience. Some of these patients had never had any dental work carried out under 
local anaesthetic before and this could have been assessed during recruitment in 
order to reduce bias on pain scores. There was a considerable variation in the pain 
scores throughout the trial reflecting the individual subjectivity of pain.  
The levels of expected pain were found to be higher than the actual pain experienced 
during the placement of TADs. The median VAS score varied from 39.87 for the 
expected levels to 13.72 for the actual pain. This correlates with previous literature, 
which shows that heightened anxiety about a procedure can lead to a greater pain 
experience. In a study in the same population group that looked at pain during 
debond Mangnall et al (2011) found that those patients who expected to have more 
pain did indeed record the procedure as more painful than those who did not expect 
the procedure to be painful. This relationship may be due to fear of the unknown or 
inaccurate information given for example by peer groups. It was clear from the written 
responses that many patients specifically cited fear of the injection and for many 
patients this will have been their first experience of an intra-oral injection. As needles 
are synonymous with a painful stimulus it is not surprising that these responses have 
been recorded.  
 
PAIN EXPERIENCE 
The level of pain after the placement of TADs peaked at 1 hour following the 
procedure reaching a median of 40.90 after which it progressively reduced 
throughout the subsequent 6 weeks to a median of 0.97. A study evaluating factors 
influencing the clinical usefulness of miniscrews examined the postoperative 
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discomfort experienced by patients having different types of miniscrews placed 
(Kuroda et al., 2007). The results of our study followed a similar progression of pain 
levels after the placement of miniscrews.  
The VAS levels reported by the patients were lower for the TADs placed with an 
overlying O-Cap than without, in all time-points for cheek and gingival discomfort. 
The Imtec O-Cap has been designed as an optional alternative means of auxiliary 
attachment to the TAD as well as for protection of adjacent tissues. There have been 
no similar studies looking into the benefits of the O-Cap after TAD placement to the 
author’s knowledge but this study shows that an overlying healing cap improves the 
overall patient’s pain experience. This reduction in pain levels could be brought about 
by the suppression of soft tissues especially immediately after the time of placement 
when the adjacent soft tissues may be tender or erythematous (Herman and Cope, 
2005).  
Gingival discomfort levels peaked at 1 hour after TAD placement whilst cheek 
discomfort levels peaked at 24 hours after the procedure reaching medians of 48.4 
and 42.1 respectively. Such high ratings of pain levels occurring in the first few hours 
following placement reflect the time when the patient is getting used the sensation of 
the presence of the TAD in place and the local anaesthetic starts to wear off. The 
overall actual pain scores reduced consistently throughout the six weeks until recall 
appointment reaching a median of 1 with a range of values from 0 to 39.7. This 
pattern of pain level rating has been reported to follow a similar course in most 
orthodontic interventions (Erdinç and Dinçer 2004; Leavitt et al., 2002) 
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ANALGESIA  
Patients are usually advised to take pain relief shortly after orthodontic intervention. 
Despite this only half the subjects in the sample reported any intake of such 
medication. The type of pain relief taken by the subjects varied from Paracetamol, 
Ibuprofen, Co-codamol to Gengigel and Beechams sachets. Relief wax was also 
included in the comments at two time-points for one of the patients. The frequency of 
pain relief intake was higher at the immediate post-operative time period but 
progressively reduced by the end of the six-week study. This correlates to the course 
of pain level ratings reported by the same patients.  
 
4.2 Effect of the O-Cap 
Cheek discomfort resulted in a different pattern of VAS scores to gingival discomfort 
despite the similar large variation illustrated by the range of VAS values for each of 
the time-points. The pain levels for cheek discomfort built up during the first 24 hours 
after placement whilst those for gingival discomfort peaked immediately 1 hour after 
placement. Both slowly reduced during the rest of the assessed time period to a 
similar low level at 6 weeks. The TADs in situ following insertion clearly have a 
stronger influence on the overall patient’s pain experience than the actual 
intervention.  
 
There was a higher pain level scored with the TAD having no O-cap at all time-points 
with statistically significant difference in VAS scores at 4 hours (p<0.05), 24 hour 
(p<0.05) and 1 week (p<0.0005) for cheek discomfort. The higher pain levels for 
gingival discomfort were statistically significant at 1 week (p<0.05) and 2 weeks 
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(p<0.05). The resultant comments in the questionnaires indicate that whilst the 
percentage of patients rating the control side remained constant, the percentage of 
patients rating the O-Cap side as more uncomfortable reduced drastically. Therefore, 
the null hypothesis that placing an O-Cap has no effect on the discomfort 
experienced in the first six weeks following placement can be rejected. 
 
The statistical tests for possible correlations between expected and actual pain levels 
showed mild correlations, which were not statistically significant for any of the time-
points. This should be considered with caution since the size of the sample is small.  
 
Patients have different pain thresholds. Placing TADs at the very beginning of 
treatment does not give enough opportunity to assess the patient’s anxiety levels and 
general response to treatment. Alternatively, reinforcing anchorage following 
alignment, might offer the benefit of being able to control the patient’s increased 
anxiety during the first phase of treatment, thus reducing the actual pain experienced.  
 
Patients are usually warned about the possible discomfort experienced during the 
placement of TADs along with that of the administered local anaesthetic that always 
accompanies this procedure. In view of these results patients should also be 
informed about the discomfort throughout the first few weeks as well as the need for 
pain relief during this period at the consent process.  
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5.1 Conclusions 
 
Discomfort is experienced in the cheeks and gums during and following the 
placement of TADs. 
 
The levels of discomfort expected during the placement of TADs are significantly 
greater than the actually experienced discomfort. 
 
Placement of an O-Cap over the TADs reduces the level of discomfort during the first 
6 weeks especially as the local anaesthetic wears off.  
 
The highest level of cheek discomfort experienced peaks at 4 hours following 
placement whilst for gum discomfort at 1 hour following placement. 
 
Patients find extractions of teeth more painful than having TADs placed. 
 
        
5.2 Null hypotheses 
Placement of an ‘o’ cap does not affect discomfort experienced in the first 6 weeks of 
treatment 
v Rejected 
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5.3 Recommendations for clinical practice  
There are many procedures in orthodontics, which may prove to be of discomfort for 
our patients, but as clinicians we have a duty to inform them during the consent 
process and to make the experience as comfortable as possible. Placement of TADs 
will be more comfortable if local anesthesia is administered in the gentlest way and 
O-Caps are used during the first 6 weeks following placement. It is beneficial to 
reassure anxious patients that the experience of placing TADs will not be as bad as 
could be expected, and is less uncomfortable than a tooth extraction.  
   
5.4 Further research	    
Further research is required into the patient experience related to placement and use 
of TADs. The main trial expected to follow-up this pilot trial will be designed to assess 
the effect of different types of TADs on the discomfort levels experienced by the 
patients.  
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APPENDIX 1: QUESTIONNAIRE 
Envelope No: ____________ 
We would like to thank you for taking part in our study. Here are some questionnaires 
that we would like you to complete. These consist of short simple questions just 
before and after having your TADs placed, then 1 hour, 4 hours, 24hours, 1 week, 2 
weeks and finally at your recall outpatient appointment. Please mark the line below 
the cartoon faces. Someone will be present to ask the questions and answer any 
queries. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Questionnaire A: pre-placement   DATE:  Env:    
1. How do you feel about having TADs placed?  
 
	  	  	  	  	  	  	  	  	  	  	  	  	   
 
2. Is there anything in particular that you are concerned about? 
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  _____________________________________________________________	  
	  
3. How uncomfortable do you expect placing the TADs will be? 	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Questionnaire B: post-placement   DATE:   Env:   
1. How uncomfortable was the placement of the TAD?	  	  
	  
	  
2. Was one side more uncomfortable than the other? Please circle. 
 
YOUR RIGHT / YOUR LEFT / SAME 
    
3. What was the worst part of having the TAD placed? 
 
            ________________________________________________________ 
 
4. How uncomfortable does your cheek feel against the TAD on your RIGHT side?  
 
 
	  
5. How uncomfortable does your cheek feel against the TAD on your LEFT side? 
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Questionnaire C: 1 hour post placement   DATE:  Env:   
1. How uncomfortable are the TADs?  
 
 
2. Is one side more uncomfortable than the other? Please circle. 
 
YOUR RIGHT / YOUR LEFT / SAME 
 
3. How uncomfortable is the gum around the TAD on the RIGHT side?  
 
4. How uncomfortable is the gum around the TAD on the LEFT side?	   
	  
5. How uncomfortable does your cheek feel against the TAD on the RIGHT hand 
side? 
 	  
6. How uncomfortable does your cheek feel against the TAD on the LEFT 
hand side?	        
  
7. Have you taken any pain relief eg. tablets?  Yes / No 
 
If yes, which type? ____________________________ 
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Questionnaire D: 4 hours post placement  DATE:  Env: 
1. How uncomfortable are the TADs? 
  
 
2. Is one side more uncomfortable than the other? Please circle. 
 
YOUR RIGHT / YOUR LEFT / SAME 
 
3. How uncomfortable is the gum around the TAD on the RIGHT side?  
 
4. How uncomfortable is the gum around the TAD on the LEFT side?	   
	  
5. How uncomfortable does your cheek feel against the TAD on the RIGHT 
hand side? 
 	  
6. How uncomfortable does your cheek feel against the TAD on the LEFT 
hand side?	        
  
7. Have you taken any pain relief eg. tablets?  Yes / No 
 
If yes, which type? ____________________________ 
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Questionnaire E: 24 hours post placement  DATE:  Env:   
1. How uncomfortable are the TADs?  
 
 
2. Is one side more uncomfortable than the other? Please circle. 
 
YOUR RIGHT / YOUR LEFT / SAME 
 
3. How uncomfortable is the gum around the TAD on the RIGHT side?  
 
4. How uncomfortable is the gum around the TAD on the LEFT side?	   
	  
5. How uncomfortable does your cheek feel against the TAD on the RIGHT hand 
side? 
 	  
6. How uncomfortable does your cheek feel against the TAD on the LEFT hand 
side? 
	          
7. Have you taken any pain relief eg. tablets?  Yes / No 
 
If yes, which type? ____________________________ 
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Questionnaire F: 1 week post placement   DATE:  Env:   
1. How uncomfortable are the TADs? 
  
 
2. Is one side more uncomfortable than the other? Please circle. 
 
YOUR RIGHT / YOUR LEFT / SAME 
 
3. How uncomfortable is the gum around the TAD on the RIGHT side?  
 
4. How uncomfortable is the gum around the TAD on the LEFT side?	   
	  
5. How uncomfortable does your cheek feel against the TAD on the RIGHT hand 
side? 
 	  
6. How uncomfortable does your cheek feel against the TAD on the LEFT hand 
side?	          
7. Have you taken any pain relief eg. tablets?  Yes / No 
 
If yes, which type? ____________________________ 
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Questionnaire G: 2 weeks post placement  DATE:  Env:   
1. How uncomfortable are the TADs? 
  
 
2. Is one side more uncomfortable than the other? Please circle. 
 
YOUR RIGHT / YOUR LEFT / SAME 
 
3. How uncomfortable is the gum around the TAD on the RIGHT side?  
 
4. How uncomfortable is the gum around the TAD on the LEFT side?	   
	  
5. How uncomfortable does your cheek feel against the TAD on the RIGHT hand 
side? 
 	  
6. How uncomfortable does your cheek feel against the TAD on the LEFT hand 
side?	          
7. Have you taken any pain relief eg. tablets?  Yes / No 
 
If yes, which type? ____________________________ 
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Questionnaire H: 6-8 weeks post placement (recall appt) DATE:  Env:  
1. How uncomfortable are the TADs?  
 
 
2. Is one side more uncomfortable than the other? Please circle. 
 
YOUR RIGHT / YOUR LEFT / SAME 
 
3. How uncomfortable is the gum around the TAD on the RIGHT side?  
 
4. How uncomfortable is the gum around the TAD on the LEFT side?	   
	  
5. How uncomfortable does your cheek feel against the TAD on the RIGHT hand 
side? 
 	  
6. How uncomfortable does your cheek feel against the TAD on the LEFT hand 
side? 
	          
7. Have you taken any pain relief eg. tablets?  Yes / No 
 
If yes, which type? ____________________________ 
 
 
8. What was most uncomfortable having the teeth removed or the TADs placed? 
 
__________________________________________________________ 
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APPENDIX 2: RAW DATA 
ID	  No	   AGE	  	   Gender	  
1	   15.33	   F	  
2	   14.17	   M	  
3	   10.92	   F	  
4	   12.33	   M	  
5	   13.33	   M	  
6	   14.08	   M	  
7	   13.25	   M	  
8	   14.67	   M	  
9	   12.5	   M	  
10	   14.33	   M	  
11	   15.5	   M	  
12	   17.33	   M	  
13	   13.58	   F	  
14	   14.83	   M	  
15	   14.67	   F	  
16	   14	   M	  
17	   18.08	   F	  
18	   15.5	   M	  
19	   14.42	   F	  
20	   16.5	   F	  
21	   15.58	   F	  
22	   15.58	   F	  
23	   14.25	   M	  
24	   18.08	   F	  
25	   15.67	   F	  
26	   14.75	   F	  
27	   16.08	   F	  
28	   13.42	   F	  
29	   12.33	   M	  
30	   14.08	   M	  
 
 
 
 
	  	  
	  
97	  
ID	  
VAS	  scores	  
Pre	  placement	   Post	  placement	  
Feeling	   Exp	   Dur	   1	  hr	   4	  hr	   24	  hr	   1	  wk	   2	  wk	   6	  wk	  
1	   29.87	   30.07	   11.36	   10.83	   29.14	   29.25	   27.87	   9.62	   10.1	  
2	   38.37	   59.06	   19.53	   60.17	   39.84	   0	   0	   0	   0	  
3	   19.6	   39.12	   0	   20.6	   78.65	   2.07	   0	   0	   0.97	  
4	   53.83	   34.69	   16.08	   76.27	   34.4	   16.46	   0	   0	   15.22	  
5	   38.71	   79.93	   58.25	   20.67	   58.28	   39.24	   0	   0	   0	  
6	   8.83	   57.58	   6.34	   0	   56.83	   2.67	   3.08	   6.77	   	  
7	   0	   28.58	   19.44	   39.4	   59.67	   27.95	   6.23	   0	   0	  
8	   48.66	   78.74	   4.64	   40.65	   48.36	   68.51	   18.3	   10.87	   0	  
9	   37.82	   48.93	   68.45	   94.18	   50.73	   41.72	   31.53	   24.04	   13.56	  
10	   20.33	   58.12	   21.45	   42.08	   19.46	   40.97	   58.44	   18.94	   20.6	  
11	   19.46	   39.11	   19.75	   59.7	   39.01	   19.49	   0	   0	   0	  
12	   39.88	   40.59	   20.37	   20.7	   20.11	   40.54	   79.86	   20.96	   0	  
13	   12.02	   19.64	   0	   30.63	   6.14	   31.64	   0	   0	   0	  
14	   38.88	   39.48	   0	   39.83	   40.06	   20.46	   0	   0	   0	  
15	   16.29	   39.16	   4.89	   81.81	   39.25	   0	   0	   0	   0	  
16	   12.31	   25.17	   1.7	   30.2	   38.57	   39.78	   20.62	   2.98	   1.51	  
17	   0	   40.07	   0	   60.64	   79.14	   79.76	   19.22	   69.03	   7.35	  
18	   0	   19.86	   0	   81.83	   19.29	   40.15	   19.82	   0	   0	  
19	   39.01	   39.05	   58.51	   40.48	   19.67	   79.08	   58.96	   39.37	   20.48	  
20	   67.65	   72.65	   32.53	   32.09	   38.36	   46.36	   27.19	   18.93	   26.97	  
21	   79.15	   80.47	   39.3	   80.61	   59.41	   20.84	   38.7	   19.75	   19.81	  
22	   30.81	   48.21	   0	   28.4	   81.63	   34.48	   20.11	   25.25	   24.32	  
23	   20.06	   38.94	   18.82	   39.78	   20.14	   0	   0	   18.15	   0	  
24	   18.99	   48.95	   48.32	   47.21	   28.67	   26.48	   49.43	   39.15	   34.03	  
25	   19.53	   37.96	   0	   81.36	   20.62	   59.58	   38.91	   19.27	   20.63	  
26	   39.05	   79.01	   20.6	   81.47	   0	   20.66	   0	   0	   0	  
27	   7.25	   10.29	   8.46	   27.33	   28.09	   8.56	   7.59	   9.19	   7.59	  
28	   39.79	   39.66	   23.07	   60.16	   59.45	   20.04	   0	   0	   0	  
29	   19.06	   40.56	   0	   41.14	   20.63	   0	   0	   0	   0	  
30	   19.03	   57.87	   0	   60.33	   100	   78.58	   58.8	   78.53	   39.71	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ID	  
VAS scores for cheek discomfort: Control 
0	  hr	   1	  hr	   4	  hr	   24	  hr	   1	  wk	   2	  wks	   6	  wks	  
1	   18.2	   68.51	   83.71	   94.92	   30.88	   34.73	   30.16	  
2	   39.12	   54.33	   82.89	   93.86	   48.47	   31.34	   20.62	  
3	   39.01	   80.08	   80.12	   85.1	   52.52	   28.41	   20.17	  
4	   0	   80.29	   79.48	   82.09	   40.04	   0	   0	  
5	   0	   60.23	   78.82	   81.76	   79.12	   21.45	   39.92	  
6	   5.49	   44.1	   65.02	   80.51	   100	   20.12	   39.2	  
7	   68.37	   74.86	   62.33	   79.29	   59.24	   0	   19.09	  
8	   20.14	   41.02	   59.06	   75.04	   30.34	   27.95	   29.24	  
9	   20.52	   39.27	   58.7	   68.91	   28.13	   29.87	   9.88	  
10	   19.69	   39.16	   58.65	   63.1	   27.38	   28.43	   8.31	  
11	   19.72	   20.1	   56	   59.62	   39.43	   19.2	   19.35	  
12	   51.78	   4.98	   51.92	   59.08	   78.87	   40.08	   39.15	  
13	   55.05	   54.81	   51	   58.96	   39.23	   20.85	   38.56	  
14	   7.65	   7.41	   46.43	   43.94	   47.87	   34.9	   32.07	  
15	   30.99	   14.97	   45	   42.86	   59.69	   51.24	   10.96	  
16	   39.6	   79.53	   39.19	   40.78	   79.5	   19.63	   40.43	  
17	   38.72	   100	   38	   40.78	   0	   0	   0	  
18	   16.35	   35.42	   34.06	   39.54	   0	   0	   0	  
19	   10.58	   28.2	   30.08	   31.22	   21.31	   2.86	   1.58	  
20	   45.79	   43.29	   29.06	   29.1	   0	   0	   0	  
21	   0	   0	   27.81	   28.39	   27.15	   9.43	   9.05	  
22	   0	   0	   21.45	   26.62	   0	   0	   0	  
23	   20.37	   21.48	   20.5	   19.94	   0	   0	   0	  
24	   38.88	   19.67	   20.14	   19.78	   0	   0	   0	  
25	   0	   38.59	   19.64	   10.7	   8.39	   4.82	   0	  
26	   19.8	   18.28	   19.63	   0	   0	   0	   0	  
27	   18.45	   18.03	   17.17	   0	   44.41	   15.99	   	  
28	   15.73	   34.72	   16.24	   0	   0	   0	   0	  
29	   0	   10.75	   8.46	   0	   0	   0	   0	  
30	   0	   19.33	   0	   0	   0	   0	   0	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  ID	  
VAS scores for cheek discomfort: O-Cap 
0	  hr	   1	  hr	   4	  hr	   24	  hr	   1	  wk	   2	  wks	   6	  wks	  
1	   9.81	   8.94	   10.47	   12.03	   9.35	   8.95	   8.56	  
2	   39.32	   0	   19.96	   0	   0	   0	   0	  
3	   50.65	   4.6	   11.84	   8.46	   8.93	   9.04	   0	  
4	   15.41	   34.53	   75.24	   14.15	   15.36	   0	   0	  
5	   79.48	   59.35	   58.58	   79.4	   0	   0	   0	  
6	   4.73	   3.66	   15.23	   27.18	   5.75	   2.16	   	  
7	   0	   28.4	   29.44	   38.15	   0	   0	   0	  
8	   17.31	   12.94	   28.83	   0	   0	   0	   0	  
9	   33.55	   15.48	   49.25	   6.19	   6.21	   11.21	   37.98	  
10	   43.16	   59.77	   21.24	   19.55	   20.84	   20.6	   3.62	  
11	   58.89	   18.95	   20.11	   18.98	   0	   20.57	   19.59	  
12	   40.08	   0	   21.46	   0	   0	   0	   0	  
13	   0	   38.86	   34.87	   35.56	   0	   0	   0	  
14	   0	   39.03	   79.18	   19.57	   0	   0	   0	  
15	   5.8	   27.4	   13.2	   28.14	   0	   0	   0	  
16	   9.45	   6.66	   20.2	   83.99	   25.37	   3.69	   1.95	  
17	   20.07	   39.55	   60.53	   28	   0	   3.01	   8.83	  
18	   20.92	   19.54	   18.85	   21.29	   20.3	   0	   0	  
19	   39.09	   19.35	   0	   19.15	   19.78	   0	   0	  
20	   24.35	   26.24	   24.51	   24.75	   24	   17.85	   10.29	  
21	   40.65	   78.51	   40.02	   40.12	   19.21	   40.21	   21.05	  
22	   26.4	   26.44	   84.17	   29.06	   18.15	   35.04	   17.19	  
23	   19.54	   18.61	   19.45	   0	   0	   20.63	   	  
24	   68.72	   12.92	   30.52	   44.2	   38.1	   42.98	   53.61	  
25	   19.44	   100	   18.45	   59.76	   38.58	   19.64	   17.83	  
26	   0	   0	   20.27	   40.8	   0	   0	   0	  
27	   6.47	   8.05	   7.78	   7.58	   10.73	   9.01	   10.45	  
28	   39.62	   39.06	   39.31	   30.27	   0	   0	   0	  
29	   0	   20.18	   0	   0	   0	   0	   0	  
30	   0	   80.06	   100	   100	   79.15	   19.79	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ID	  
VAS scores for gingival discomfort: Control 
1	  hr	   4	  hr	   24	  hr	   1	  wk	   2	  wks	   6	  wks	  
1	   28.89	   30.32	   28.79	   9.75	   9.94	   8.29	  
2	   79.15	   79.17	   0	   0	   0	   0	  
3	   62.26	   28.11	   0	   0	   8.42	   0	  
4	   74.98	   35.17	   0	   0	   0	   14.46	  
5	   58.73	   78.6	   18.91	   0	   0	   0	  
6	   61.66	   55.08	   46.79	   27.52	   9.13	   	  
7	   39.25	   38.34	   19.32	   18.86	   0	   0	  
8	   63.59	   0	   0	   0	   0	   0	  
9	   83.66	   53.45	   96.22	   31.2	   50.29	   59.45	  
10	   19.96	   20.16	   37.53	   20.85	   19.48	   3.65	  
11	   20.41	   0	   0	   18.64	   0	   0	  
12	   21.16	   20.64	   39.31	   79.23	   21.52	   39.89	  
13	   1.4	   19.62	   30.88	   0	   0	   0	  
14	   0	   0	   0	   0	   0	   0	  
15	   86.11	   66.29	   0	   0	   0	   0	  
16	   34.6	   29.88	   34.56	   19.71	   3.67	   1.78	  
17	   60.05	   80.03	   91.37	   48.16	   34.62	   8.6	  
18	   80.68	   79.9	   0	   20.51	   0	   0	  
19	   19.35	   0	   39.14	   59.02	   39.23	   38.69	  
20	   49.43	   48.57	   34.53	   38.35	   20.16	   26.31	  
21	   39.08	   58.14	   58.7	   38.99	   38.31	   20.39	  
22	   49.56	   82.56	   49.83	   32.82	   34.83	   28.71	  
23	   18.21	   19.38	   0	   0	   0	   0	  
24	   47.29	   29.52	   31.11	   50.65	   52.09	   50.62	  
25	   100	   38.95	   58.43	   39.44	   19.64	   36.24	  
26	   59.29	   0	   0	   0	   0	   0	  
27	   10.15	   8.04	   9.05	   6.68	   29.29	   7.25	  
28	   79.74	   59.97	   31.78	   0	   0	   0	  
29	   40.66	   0	   0	   0	   0	   0	  
30	   39.69	   39	   38.25	   79.03	   19.5	   38.56	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ID	  
VAS scores for gingival discomfort: O-Cap 
1	  hr	   4	  hr	   24	  hr	   1	  wk	   2	  wks	   6	  wks	  
1	   10.15	   10.12	   9.53	   10.07	   8.91	   8.59	  
2	   0	   79.77	   0	   0	   0	   0	  
3	   6.83	   28.69	   0	   0	   0	   0	  
4	   74.52	   34.94	   0	   0	   15.07	   0	  
5	   39.36	   78.51	   57.22	   0	   0	   0	  
6	   7.11	   44.94	   58.07	   15.08	   4.1	   	  
7	   58.15	   68.32	   17.48	   0	   0	   0	  
8	   18.84	   0	   0.87	   0	   0	   0	  
9	   67.21	   10.59	   0.95	   9.67	   7.98	   11.98	  
10	   40.07	   38.67	   21.21	   19.96	   21.21	   5.52	  
11	   19.94	   58.85	   0	   0	   0	   18.7	  
12	   0	   21.97	   18.84	   0	   0	   0	  
13	   12.56	   24.15	   33.99	   0	   0	   0	  
14	   57.87	   79.36	   20.27	   19.01	   0	   0	  
15	   65.5	   13.38	   0	   0	   0	   0	  
16	   16.04	   27.83	   34.56	   30.59	   2.05	   1.78	  
17	   20.22	   59.49	   29.65	   8.06	   7.93	   9.68	  
18	   19.76	   19.66	   0	   0	   0	   0	  
19	   39.51	   0	   18.91	   39	   20.06	   20.48	  
20	   31.19	   31.03	   28.78	   27.62	   20.16	   10.65	  
21	   59.02	   39.15	   38.25	   39.71	   18.38	   20.39	  
22	   25.19	   82.89	   18.78	   19.32	   23.18	   24.16	  
23	   18.69	   20.15	   0	   0	   38.32	   	  
24	   34.27	   29.45	   31.5	   22.86	   32.27	   50.63	  
25	   100	   19.54	   56.23	   38.9	   19.55	   37.95	  
26	   59.82	   0	   20	   0	   0	   0	  
27	   46.6	   7.36	   10.23	   6.68	   7.28	   6.78	  
28	   79.46	   39.69	   18.07	   0	   0	   0	  
29	   40.07	   0	   0	   0	   0	   0	  
30	   58.89	   100	   79.44	   58.64	   20.12	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B = Bonjela     I = Ibuprofen 
C = Calpol     N = Neurofen 
CO = CO-Codamol    P = Paracetamol 
G = Gengigel    W= Wax 
 
 
Pain	  relief	  :	  1	  =	  yes	  	  	  2	  =	  no	  
1	  hr	   Type	   4	  hrs	   Type	   24	  hrs	   Type	   1wk	   Type	   2	  wk	   Type	   6	  wk	  
2	   	   2	   	   1	   P	   2	   	   2	   	   2	  
1	   P	   1	   P	   2	   	   2	   	   2	   	   2	  
1	   C	   2	   	   2	   	   2	   	   2	   	   2	  
1	   C	   2	   	   2	   	   2	   	   2	   	   2	  
1	   	   1	   P	   1	   P	   2	   	   2	   	   2	  
2	   	   2	   	   2	   	   2	   	   2	   	   	  
1	   I	   2	   	   2	   	   2	   	   2	   	   2	  
2	   	   2	   	   2	   	   2	   	   2	   	   2	  
1	   P	   2	   	   2	   	   2	   W	   2	   W	   2	  
2	   	   2	   	   2	   	   1	   I	   2	   	   2	  
1	   P	   1	   P	   2	   	   2	   	   2	   	   2	  
2	   	   2	   	   2	   	   2	   	   2	   	   2	  
1	   P	   1	   P	   1	   P	   2	   	   2	   	   2	  
2	   	   2	   	   2	   	   2	   	   2	   	   2	  
2	   	   1	   B	   2	   	   2	   	   2	   	   2	  
1	   P	   2	   	   2	   	   2	   	   2	   	   2	  
2	   	   1	   P	   1	   G	   1	   B	   1	   G	   2	  
2	   	   1	   I	   2	   	   2	   	   2	   	   2	  
1	   P	   2	   	   1	   P	   1	   P	   2	   	   2	  
2	   	   1	   I	   1	   I	   1	   I	   2	   	   2	  
2	   	   1	   P	   2	   	   2	   	   2	   	   2	  
2	   	   1	   P	   2	   	   2	   	   2	   	   2	  
2	   	   2	   	   2	   	   2	   	   2	   	   2	  
1	   P	   2	   	   2	   	   2	   	   2	   	   2	  
1	   I	   1	   I	   2	   	   2	   	   2	   	   2	  
2	   	   1	   N	   2	   	   2	   	   2	   	   2	  
1	   I	   1	   I	   2	   	   2	   	   2	   	   2	  
2	   	   1	   C	   2	   	   2	   	   2	   	   2	  
1	   	   2	   	   2	   	   2	   	   2	   	   2	  
2	   	   1	   CO	   1	   CO	   1	   B	   1	   CO	   2	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